Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,255,635
  • Shares Outstanding, K 110,268
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • EBIT $ -125 M
  • EBITDA $ -133 M
  • 60-Month Beta 1.00
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.77

Options Overview Details

View History
  • Implied Volatility 121.77% ( +2.75%)
  • Historical Volatility 64.19%
  • IV Percentile 81%
  • IV Rank 51.84%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.31
  • Today's Volume 12,349
  • Volume Avg (30-Day) 17,609
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 168,912
  • Open Int (30-Day) 195,685

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.24
  • Number of Estimates 10
  • High Estimate -0.21
  • Low Estimate -0.31
  • Prior Year -0.23
  • Growth Rate Est. (year over year) -4.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.57 +6.22%
on 10/01/24
70.64 -8.91%
on 09/23/24
-6.13 (-8.70%)
since 09/20/24
3-Month
47.31 +36.00%
on 08/05/24
72.36 -11.08%
on 09/20/24
+13.44 (+26.40%)
since 07/19/24
52-Week
8.28 +677.05%
on 10/26/23
99.41 -35.28%
on 02/28/24
+54.31 (+541.48%)
since 10/20/23

Most Recent Stories

More News
Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future

Viking recently announced the results of an early-stage clinical trial for VK0214.

VKTX : 64.34 (-2.22%)
Where Will Viking Therapeutics Be in 5 Years?

We could be witnessing the birth of a major player in the biotech industry.

VKTX : 64.34 (-2.22%)
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics

It's hard to go wrong with either company, but one is more appealing.

VKTX : 64.34 (-2.22%)
MS : 118.28 (-2.30%)
SMMT : 20.50 (-3.35%)
LLY : 906.13 (-1.29%)
The Ultimate Biotech Stock to Buy With $100 Right Now

This company is operating in one of today's hottest markets.

VKTX : 64.34 (-2.22%)
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts

The investment bank analysts who follow these stocks think they can soar even further, with some caveats.

VKTX : 64.34 (-2.22%)
SMMT : 20.50 (-3.35%)
MRK : 106.34 (-2.17%)
SGMT Stock Up 12.6% on FDA Fast Track for Liver Disease Drug

Sagimet Biosciences’ SGMT stock rose 12.6% on Tuesday after it announced that the FDA has granted breakthrough therapy designation (“BTD”) to its lead pipeline candidate, denifanstat, for treating...

VKTX : 64.34 (-2.22%)
MDGL : 208.89 (-2.59%)
AKRO : 30.90 (-1.06%)
SGMT : 5.57 (+2.96%)
Why Viking Therapeutics Stock Topped the Market Today

An analyst waxed bullish on the company's leading pipeline program.

VKTX : 64.34 (-2.22%)
MS : 118.28 (-2.30%)
LLY : 906.13 (-1.29%)
Is Viking Therapeutics Stock a Buy?

The company is in the spotlight for one of its programs, but it's got others that also have promise.

VKTX : 64.34 (-2.22%)
LLY : 906.13 (-1.29%)
IQV : 231.19 (-2.32%)
Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics

One of them is performing much better than the other this year.

VKTX : 64.34 (-2.22%)
SMMT : 20.50 (-3.35%)
LLY : 906.13 (-1.29%)
Is Viking Therapeutics Ready For Another Surge?

Viking Therapeutics' promising weight loss drug could revolutionize the obesity market and propel the company's stock price to new highs.

VKTX : 64.34 (-2.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 68.24
2nd Resistance Point 67.25
1st Resistance Point 65.80
Last Price 64.34
1st Support Level 63.36
2nd Support Level 62.37
3rd Support Level 60.92

See More

52-Week High 99.41
Fibonacci 61.8% 64.60
Last Price 64.34
Fibonacci 50% 53.85
Fibonacci 38.2% 43.09
52-Week Low 8.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar